JPRN-UMIN000004800
Completed
未知
Effect of Procalcitonin Guidance for Duration of Antibiotic Therapy on Antibiotics Use in Aspiration Pneumonia Randomized Controlled Trial - Procalcitonin-Guided Antibiotics Use in aspiration pneumonia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hamamatsu Medical Center
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\)Known severe allergy to any drugs (2\)Sepsis, severe infectious disease (3\)Fatal and severe underlying disease, malignancy, COPD, heart failure and so on. (4\)Patients who cannot safely receive cessation of eating or hydration as a treatment for aspiration pneumonia because of dementia.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Procalcitonin guided reduction of the duration of antibiotic therapy in Community Acquired PneumoniaCommunity Acquired Pneumonia (CAP)RespiratoryPneumoniaISRCTN04176397niversity Hospital Basel (Switzerland)250
Completed
Not Applicable
The use of an infection biomarker (Procalcitonin blood level) to guide antibiotic use in intensive care patientsACTRN12610000809033Prince of Wales Hospital400
Completed
Not Applicable
Prospective study of the utility of procalcitonin (PCT) in patients with pneumonia.community-acquired pneumonia (CAP) nursing and healthcare-associated pneumonia (NHCAP)JPRN-UMIN000011566Health Promoting Association for Respiratory Medicine of Nishi-Nippon1,000
Completed
Not Applicable
Assessment of clinical usefulness of Procalcitonin (PCT) measurement in pneumonia patientscommunity-acquired pneumonia, hospital-acquired pneumonia, healthcare-associated pneumoniaJPRN-UMIN000003368agasaki evaluation organization for clinical interventions300
Not yet recruiting
Not Applicable
A Clinical trial to evaluate the safety of early discontinuation of antibiotics in children with cancer and infections based on procalcitonin levelsHealth Condition 1: C00-D49- NeoplasmsCTRI/2020/01/022997AIIMS